Health
Metformin treatment linked to slowed cognitive decline – EurekAlert
A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates.
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dement…
-
Business21 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Business22 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News21 hours agoDid AI write your accounting expert’s report? – Proctor
-
Noosa News22 hours agoYear 12 student from Wellington Point State High School dies four days before graduation